Fig. 6From: Pangenome diversification and resistance gene characterization in Salmonella Typhi prioritized RfaJ as a significant therapeutic markerMolecular docking analysis of shortlisted compounds A DB15637 (Fluzoparib), B DB15688 (Zavegepant), C DB12411 (Bemcentinib), and D DB00549 (Zafirlukast)Back to article page